KYMR Insider Trading Activity - Kymera Therapeutics Inc.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Kymera Therapeutics Inc.

Goto Prev, 0, 1, 2, 3, 4, 5, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2022-10-28 Sale	2022-11-01 7:36 pm	Kymera Therapeutics Inc.	KYMR	Booth Bruce Director	288,702	$30.26	$8,735,143	1,049,540 (Indirect)	View
2022-10-28 Sale	2022-11-01 7:34 pm	Kymera Therapeutics Inc.	KYMR	Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	288,702	$30.26	$8,735,143	6,586,996 (Indirect Direct)	View
2022-08-22 Purchase	2022-08-23 5:35 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes	545,525	$26	$14,183,650	329,944 (Indirect Direct)	View
2022-05-26 Purchase	2022-05-31 7:50 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes	289,426	$14.34	$4,150,321	290,827 (Indirect Direct)	View
2022-05-20 Purchase	2022-05-24 8:09 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes	10,100	$14	$141,394	276,962 (Indirect Direct)	View
2022-05-05 Purchase	2022-05-09 7:20 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes	250,000	$19.46	$4,865,365	276,925 (Indirect Direct)	View
2022-01-27 Purchase	2022-01-31 7:44 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks	130,309	$38.96	$5,076,473	1,664,653 (Indirect Direct)	View
2022-01-24 Purchase	2022-01-26 7:43 pm	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks	272,767	$37.76	$10,300,637	1,612,471 (Indirect Direct)	View
2022-01-12 Sale	2022-01-14 5:01 pm	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	15,000	$51.85	$777,684	54,488 (Direct)	View
2022-01-10 Sale	2022-01-12 7:30 pm	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	48,000	$53.31	$2,558,742	2,229,186 (Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2022-11-03 Option Award	2022-11-03 7:22 pm	N/A 2032-11-02	Kymera Therapeutics Inc.	KYMR	Sandor Victor Director	24,000	$0	24,000 (Direct)	View
2022-10-21 Exercise	2022-10-24 08:00 am	N/A N/A	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$2.08	221,178 (Direct)	View
2022-10-21 Exercise	2022-10-24 08:00 am	N/A 2029-08-28	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$0	221,178 (Direct)	View
2022-10-17 Exercise	2022-10-17 8:12 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$2.08	221,178 (Direct)	View
2022-10-17 Exercise	2022-10-17 8:12 pm	N/A 2029-08-28	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$0	221,178 (Direct)	View
2022-10-17 Exercise	2022-10-17 8:09 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	59,732	$2.08	1,122,903 (Direct)	View
2022-10-17 Exercise	2022-10-17 8:09 pm	N/A 2029-05-22	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	59,732	$0	1,122,903 (Direct)	View
2022-07-06 Option Award	2022-07-08 4:10 pm	N/A 2032-07-05	Kymera Therapeutics Inc.	KYMR	Morgan Leigh Director	24,000	$0	24,000 (Direct)	View
2022-06-29 Option Award	2022-07-01 4:05 pm	N/A 2032-06-28	Kymera Therapeutics Inc.	KYMR	Ridloff Elena Director	9,000	$0	9,000 (Direct)	View
2022-06-15 Option Award	2022-06-17 7:20 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes	12,000	$0	4,126,451 (Indirect)	View
2022-06-15 Option Award	2022-06-16 4:06 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Hrustanovic Gorjan Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:06 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Nicholson Donald William Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:06 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Esposito Pamela Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:05 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Ridloff Elena Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:05 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Booth Bruce Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:05 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Albers Jeffrey W. Director	12,000	$0	12,000 (Direct)	View
2022-06-15 Option Award	2022-06-16 4:05 pm	N/A 2032-06-14	Kymera Therapeutics Inc.	KYMR	Horobin Joanna Director	12,000	$0	12,000 (Direct)	View
2022-05-04 Exercise	2022-05-04 09:02 am	N/A N/A	Kymera Therapeutics Inc.	KYMR	Gollob Jared Chief Medical Officer	9,792	$2.08	196,076 (Direct)	View
2022-05-04 Exercise	2022-05-04 09:02 am	N/A 2028-10-31	Kymera Therapeutics Inc.	KYMR	Gollob Jared Chief Medical Officer	20,000	$0	196,076 (Direct)	View
2022-05-04 Exercise	2022-05-04 09:02 am	N/A N/A	Kymera Therapeutics Inc.	KYMR	Gollob Jared Chief Medical Officer	10,208	$1.31	196,076 (Direct)	View
2022-05-03 Exercise	2022-05-03 7:27 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	20,000	$2.08	548,623 (Direct)	View
2022-05-03 Exercise	2022-05-03 7:27 pm	N/A 2029-05-22	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	20,000	$0	548,623 (Direct)	View
2022-05-03 Exercise	2022-05-03 7:26 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	20,000	$2.08	220,713 (Direct)	View
2022-05-03 Exercise	2022-05-03 7:26 pm	N/A 2029-08-28	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	20,000	$0	220,713 (Direct)	View
2021-06-16 Option Award(A)	2022-04-15 4:15 pm	N/A 2031-06-15	Kymera Therapeutics Inc.	KYMR	Ridloff Elena Director	10,459	$0	10,459 (Direct)	View
2021-03-12 Option Award(A)	2022-04-15 4:15 pm	N/A 2031-03-11	Kymera Therapeutics Inc.	KYMR	Ridloff Elena Director	20,919	$0	20,919 (Direct)	View
2022-03-01 Option Award	2022-03-03 4:31 pm	N/A 2032-02-29	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	275,100	$0	275,100 (Direct)	View
2022-03-01 Option Award	2022-03-03 4:30 pm	N/A 2032-02-29	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	93,300	$0	120,814 (Direct)	View
2022-03-01 Option Award	2022-03-03 4:30 pm	N/A 2032-02-29	Kymera Therapeutics Inc.	KYMR	Gollob Jared Chief Medical Officer	88,400	$0	113,057 (Direct)	View
2022-03-01 Option Award	2022-03-03 4:30 pm	N/A 2032-02-29	Kymera Therapeutics Inc.	KYMR	Caughey Elaine Chief Business Officer	48,000	$0	48,000 (Direct)	View
2022-01-18 Option Award	2022-01-19 5:35 pm	N/A 2032-01-17	Kymera Therapeutics Inc.	KYMR	MARAGANORE JOHN Director	24,000	$0	24,000 (Direct)	View
2022-01-14 Exercise	2022-01-14 5:30 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	10,000	$2.08	548,623 (Direct)	View
2022-01-14 Exercise	2022-01-14 5:30 pm	N/A 2029-05-22	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	10,000	$0	548,623 (Direct)	View
2022-01-14 Exercise	2022-01-14 5:15 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$2.08	207,413 (Direct)	View
2022-01-14 Exercise	2022-01-14 5:15 pm	N/A 2029-08-28	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	10,000	$0	207,413 (Direct)	View
2022-01-12 Exercise	2022-01-14 5:01 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	15,000	$2.08	54,488 (Direct)	View
2022-01-12 Exercise	2022-01-14 5:01 pm	N/A 2029-08-28	Kymera Therapeutics Inc.	KYMR	Jacobs Bruce N. Chief Financial Officer	15,000	$0	54,488 (Direct)	View
2022-01-10 Exercise	2022-01-12 7:30 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	48,000	$2.08	2,229,186 (Direct)	View
2022-01-10 Exercise	2022-01-12 7:30 pm	N/A 2029-11-13	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	48,000	$0	2,229,186 (Direct)	View
2021-12-16 Exercise	2021-12-16 4:49 pm	N/A N/A	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	8,000	$2.08	548,623 (Direct)	View
2021-12-16 Exercise	2021-12-16 4:49 pm	N/A 2029-05-22	Kymera Therapeutics Inc.	KYMR	Mainolfi Nello Chief Executive Officer	8,000	$0	548,623 (Direct)	View

(A) Indicate amendment filing.

Goto Prev, 0, 1, 2, 3, 4, 5, Next

Insider Trading & Ownership - Kymera Therapeutics Inc. (KYMR)